Expanded OptiVision Presbyopia Reversal Trial On SurgiLight’s Horizon
This article was originally published in The Gray Sheet
Executive Summary
SurgiLight will need additional funding to support expansion of its IDE trial for the OptiVision presbyopia reversal system, following a lawsuit filed by Merrill Lynch over its credit line